One in four people experience mild side effects from Covishield Covid-19 vaccine: Lancet study | India News
NEW DELHI: One in four people experience mild, short-lived systemic side effects after receiving either the Covid-19 preventive by Pfizer or AstraZeneca vaccine -- known as Covishield in India -- with headache, fatigue and tenderness the most common symptoms, according to a study published in the Lancet Infectious Diseases journal. The researchers from King's College London in the UK also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days. The analysis of...